TY  - JOUR

T1  - Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial

JO  - European Heart Journal

UR  - https://doi.org/10.1093/eurheartj/ehad144

PY  - 2023/03/05

AU  - Schwartz GG

AU  - Szarek M

AU  - Bhatt DL

AU  - Bittner VA

AU  - Bujas-Bobanovic M

AU  - Diaz R

AU  - Fazio S

AU  - Fras Z

AU  - Goodman SG

AU  - Harrington RA

AU  - Jukema JW et al

ED  - 

DO  - DOI: 10.1093/eurheartj/ehad144

PB  - Oxford University Press (OUP)

Y2  - 2026/10/14

ER  -